Association of Opioid, Anti-Depressant, and Benzodiazepines With Workers' Compensation Cost: A Cohort Study.
Adult
Analgesics, Opioid
/ administration & dosage
Antidepressive Agents
/ administration & dosage
Benzodiazepines
/ administration & dosage
Cohort Studies
Databases, Factual
Drug Prescriptions
/ statistics & numerical data
Female
Humans
Insurance Claim Review
Male
Middle Aged
Occupational Injuries
/ epidemiology
Odds Ratio
Pain
/ drug therapy
United States
/ epidemiology
Workers' Compensation
/ economics
Workplace
Journal
Journal of occupational and environmental medicine
ISSN: 1536-5948
Titre abrégé: J Occup Environ Med
Pays: United States
ID NLM: 9504688
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
pubmed:
20
3
2019
medline:
6
11
2020
entrez:
20
3
2019
Statut:
ppublish
Résumé
Antidepressants, benzodiazapines, and opioid medications are used to manage the pain, anxiety, or depression associated with workplace injuries. To evaluate the impact of these medications on workers' compensation costs and time lost from work. A cohort of 22,383 indemnity claims from 2008 to 2013 were evaluated for the association of prescribed medications on claim cost and delayed claim closure controlling for confounders. Claims with anti-depressant, opioid, or benzodiazepine prescriptions were 2.24 (95% CI: 2.00 to 2.51), 1.14 (95% CI: 1.02 to 1.27), and 1.38 (95% CI: 1.23 to 1.54) times more likely to remain open at the end of the study. The concurrent treatment of pain, depression or anxiety, and occupational injuries are associated with large increases in claim cost and delayed return to work.
Sections du résumé
BACKGROUND
Antidepressants, benzodiazapines, and opioid medications are used to manage the pain, anxiety, or depression associated with workplace injuries.
OBJECTIVE
To evaluate the impact of these medications on workers' compensation costs and time lost from work.
METHODS
A cohort of 22,383 indemnity claims from 2008 to 2013 were evaluated for the association of prescribed medications on claim cost and delayed claim closure controlling for confounders.
RESULTS
Claims with anti-depressant, opioid, or benzodiazepine prescriptions were 2.24 (95% CI: 2.00 to 2.51), 1.14 (95% CI: 1.02 to 1.27), and 1.38 (95% CI: 1.23 to 1.54) times more likely to remain open at the end of the study.
CONCLUSION
The concurrent treatment of pain, depression or anxiety, and occupational injuries are associated with large increases in claim cost and delayed return to work.
Identifiants
pubmed: 30889055
doi: 10.1097/JOM.0000000000001585
doi:
Substances chimiques
Analgesics, Opioid
0
Antidepressive Agents
0
Benzodiazepines
12794-10-4
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM